Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Gastroenterol. 2016 Mar 31;52(1):39–49. doi: 10.1007/s00535-016-1202-4

Fig. 4.

Fig. 4

Immunohistochemistry of SLFN5 in the human stomach. SLFN5 protein detection was performed on archived gastric tissues from A) Normal; B) Atrophic gastritis, in stroma versus glands; C) Non-atrophic gastritis (NAG); D) Multi-focal atrophic gastritis (MAG); E) Incomplete Intestinal Metaplasia that did not progress to GC (IIM→Not GC); F) Incomplete Intestinal Metaplasia that progressed to gastric cancer (IIM→GC); G) Complete Intestinal Metaplasia that did not progress to GC (CIM→Not GC); H) Complete Intestinal Metaplasia that progressed to gastric cancer (CIM→GC); I) Intestinal-type gastric cancer; J) Diffuse-type gastric cancer